494799-16-5 Usage
Description
3-cyclohex-1-en-1-yl-1H-indole-6-carboxylic acid is a chemical compound with a molecular formula C17H19NO2. It is a derivative of indole and contains a cyclohexene ring and a carboxylic acid group. 3-cyclohex-1-en-1-yl-1H-indole-6-carboxylic acid is known for its diverse range of biological activities, including anti-inflammatory and antitumor properties, making it a valuable component in pharmaceutical research and development.
Used in Pharmaceutical Industry:
3-cyclohex-1-en-1-yl-1H-indole-6-carboxylic acid is used as a key intermediate in the synthesis of various drugs and bioactive molecules. Its unique structure and functional groups contribute to the development of new therapeutic agents with potential applications in treating a wide range of diseases.
Used in Drug Delivery Systems:
3-cyclohex-1-en-1-yl-1H-indole-6-carboxylic acid is also studied for its potential as a drug delivery system. Its carboxylic acid group can be utilized to form conjugates or complexes with drug molecules, enhancing their solubility, stability, and targeted delivery to specific tissues or cells.
Used in Organic Synthesis:
Furthermore, 3-cyclohex-1-en-1-yl-1H-indole-6-carboxylic acid serves as a building block in organic synthesis. Its cyclohexene ring and carboxylic acid group provide opportunities for further chemical modifications, allowing the creation of novel compounds with tailored properties for various applications in the chemical and materials sciences.
Check Digit Verification of cas no
The CAS Registry Mumber 494799-16-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,4,7,9 and 9 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 494799-16:
(8*4)+(7*9)+(6*4)+(5*7)+(4*9)+(3*9)+(2*1)+(1*6)=225
225 % 10 = 5
So 494799-16-5 is a valid CAS Registry Number.
494799-16-5Relevant articles and documents
HEPATITIS B CORE PROTEIN MODULATORS
-
Page/Page column 162, (2018/04/13)
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound of formula:
MACROCYCLIC INDOLES AS HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 56, (2009/07/25)
The present invention relates to inhibitors of HCV replication of formula (I), the N-oxide forms, the pharmaceutically acceptable addition salts, the quaternary amines and the stereochemically isomeric forms thereof, formula (I), wherein R1; R3; and R4 have the meaning defined in the claims. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.
Compounds for the Treatment of Hepatitis C
-
Page/Page column 23, (2008/12/06)
The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.